Pinkelpause

Anmerkungen

www.doc-pies.de

Burstein GR et al. (2003) Sexually transmitted diseases treatment guidelines. Curr Opin Pediatr 15: 391-397.

Donovan B, Grulich AE. 2011. The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men. Evid Based Med. 16(5):157-8

Delere Y, Remschmidt C, Leuschner J, et al. Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis 2014;14:87

de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13(6):607-15

Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012;30 Suppl 5:F55-70 Gross GE, Werner RN, Becker JC, et al. S2k Leitlinie HPV-assoziierte Läsionen der äußeren Genitalregion und des Anus Genitalwarzen und Krebsvorstufen der Vulva, des Penis und der peri- und intraanalen Haut. AWMF 2018; AWMF-Registernummer: 082-008

Kraut AA, Schink T, Schulze-Rath R, et al. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis 2010;10:360

McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9(5):425-34

Bauer GR, Khobzi N, Coleman TA. Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: a population-based analysis. BMC Infect Dis. 2010 Dec 22;10:359.

Fleming DT, McQuillan GM, Johnson RE, Mahmias AJ, Aral SO, Lee FK, St Louis ME. Herpes simplex virus type 2 in the United States, 1976 to 1994. New Engl J Med. 1997;337:1105-1111.

Hellenbrand W, Müller B, Thierfelder W, Färber I, Hamouda O, Breuer T. 2001. Die Herpes simplex-Virus 1 (HSV1) und 2 (HSV2) Seroprävalenz in der deutschen Bevölkerung: Ein Vergleich zwischen den alten und neuen Bundesländern und Veränderungen über die Zeit. Jahrestagung der Deutschen Arbeitsgemeinschaft für Epidemiologie. Garmisch-Partenkirchen: GSF-Forschungszentrum für Umwelt und Gesundheit.

Korr G, Thamm M, Czogiel I, Poethko-Mueller C, Bremer V, Jansen K. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control. BMC Infectious DiseasesBMC series open, inclusive and trusted2017 17:471.

Malkin CE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes. 2004 Apr;11 Suppl 1:2A-23A.